Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Directorate Change

19 Aug 2020 12:25

RNS Number : 6094W
Aberdeen Latin American Inc Fd Ltd
19 August 2020
 

ABERDEEN LATIN AMERICAN INCOME FUND LIMITED

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

 

Appointment of Non-Executive Director

 

19 August 2020

 

The Board of Aberdeen Latin American Income Fund Limited (the "Company") is pleased to announce the appointment of Howard Myles as an independent non-executive Director of the Company with effect from 1 October 2020. Mr Myles was appointed after a search conducted by an independent recruitment consultancy.

 

Richard Prosser, Chairman of the Company, said: "The Directors are delighted to welcome Howard to the Board. Howard brings a wealth of knowledge in relation to closed-end funds including experience of the Latin American region.

 

He was a partner with Ernst & Young from 2001 to 2007 and was responsible for the Investment Funds Corporate Advisory team having previously been with UBS Warburg. Starting his career as an equity salesman, he then joined Touche Ross & Co in 1975 where he qualified as a chartered accountant. In 1978 he joined W Greenwell & Co. in the corporate broking team and in 1987 moved to SG Warburg Securities where he was involved in a wide range of commercial and industrial transactions in addition to leading Warburg's corporate finance function for investment funds.

 

Howard is currently Senior Independent Director of BBGI SICAV and Audit Committee Chair of Chelverton UK Dividend Trust plc. He is Chairman of JP Morgan Brazil Investment Trust plc, from which he is due to retire on 17 September 2020, and Chairman of Baker Steel Resources Trust Limited."

 

Mr Myles will stand for election as a Director at the Annual General Meeting to be held on or around 10 December 2020.

 

In accordance with paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules, Mr Myles advises that, within the last five years, he stepped down as a non-executive Director of Lazard World Trust Fund in 2019 and Aberdeen Private Equity Fund Limited in 2018.

 

There are no other disclosures required to be made for Mr Myles in respect of paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules.

 

Mr Myles does not hold any interests in any of the Company's shares.

 

 

Aberdeen Standard Capital International Limited

Company Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAKKCBBDBKDNFD
Date   Source Headline
2nd Nov 202112:36 pmRNSNet Asset Value(s)
1st Nov 20215:13 pmRNSGearing disclosure
29th Oct 202112:43 pmRNSNet Asset Value(s)
28th Oct 20211:13 pmRNSNet Asset Value(s)
27th Oct 202112:23 pmRNSNet Asset Value(s)
26th Oct 202111:26 amRNSNet Asset Value(s)
25th Oct 20213:03 pmRNSGearing Disclosure
25th Oct 202112:43 pmRNSNet Asset Value(s)
22nd Oct 20211:04 pmRNSNet Asset Value(s)
21st Oct 202112:05 pmRNSNet Asset Value(s)
20th Oct 20211:11 pmRNSNet Asset Value(s)
19th Oct 202112:29 pmRNSNet Asset Value(s)
18th Oct 202112:32 pmRNSGearing disclosure
18th Oct 202111:49 amRNSNet Asset Value(s)
15th Oct 202111:51 amRNSNet Asset Value(s)
14th Oct 202112:03 pmRNSPortfolio disclosure
14th Oct 202111:49 amRNSNet Asset Value(s)
13th Oct 202112:23 pmRNSNet Asset Value(s)
12th Oct 202112:44 pmRNSNet Asset Value(s)
11th Oct 202112:23 pmRNSGearing disclosure
11th Oct 202111:22 amRNSNet Asset Value(s)
8th Oct 20214:26 pmRNSHolding(s) in Company
8th Oct 202112:47 pmRNSNet Asset Value(s)
7th Oct 202112:29 pmRNSNet Asset Value(s)
6th Oct 20213:10 pmRNSMonth End Net Asset Value(s)
6th Oct 202111:04 amRNSNet Asset Value(s)
5th Oct 202111:30 amRNSNet Asset Value(s)
4th Oct 20213:03 pmRNSGearing disclosure
4th Oct 202112:31 pmRNSNet Asset Value(s)
4th Oct 20217:00 amRNSCompliance with Market Abuse Regulation
30th Sep 20211:59 pmRNSNet Asset Value(s)
30th Sep 20217:00 amRNSFourth Interim Dividend
29th Sep 202112:42 pmRNSNet Asset Value(s)
28th Sep 202112:30 pmRNSNet Asset Value(s)
27th Sep 20211:49 pmRNSGearing disclosure
27th Sep 202112:55 pmRNSNet Asset Value(s)
24th Sep 202111:53 amRNSNet Asset Value(s)
23rd Sep 202112:10 pmRNSNet Asset Value(s)
22nd Sep 202112:14 pmRNSNet Asset Value(s)
21st Sep 202111:54 amRNSNet Asset Value(s)
20th Sep 20213:15 pmRNSGearing disclosure
20th Sep 202112:49 pmRNSNet Asset Value(s)
17th Sep 202110:26 amRNSNet Asset Value(s)
16th Sep 202111:37 amRNSNet Asset Value(s)
15th Sep 202111:41 amRNSNet Asset Value(s)
14th Sep 202112:38 pmRNSPortfolio disclosure
14th Sep 202112:34 pmRNSNet Asset Value(s)
13th Sep 20213:06 pmRNSGearing disclosure
13th Sep 202111:32 amRNSNet Asset Value(s)
10th Sep 202111:54 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.